| Mary Hannah Rankin, FNP | |
|
1672 S Woodsage Ave Ste 120, Meridian, ID 83642-8332 | |
| (208) 515-2273 | |
| Not Available |
| Full Name | Mary Hannah Rankin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1672 S Woodsage Ave Ste 120, Meridian, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154072205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 70369 (Idaho) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 70369 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meridian Advanced Psychiatry , Llc | 8628490711 | 22 |
News Archive
Probiodrug AG, a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and multiple ascending dose (MAD) study of PQ912 in healthy volunteers.
A new study reports that chronic exposure to arsenic interferes with insulin secretion in the pancreas, which may increase the risk of diabetes.
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The average age at onset of depression was nearly two years younger in low-income countries, the investigators found. Women were twice as likely as men to suffer depression, and the major contributing factor was loss of a partner because of death, divorce or separation.
› Verified 2 days ago
| Entity Name | Meridian Advanced Psychiatry , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609412683 PECOS PAC ID: 8628490711 Enrollment ID: O20200618000604 |
News Archive
Probiodrug AG, a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and multiple ascending dose (MAD) study of PQ912 in healthy volunteers.
A new study reports that chronic exposure to arsenic interferes with insulin secretion in the pancreas, which may increase the risk of diabetes.
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The average age at onset of depression was nearly two years younger in low-income countries, the investigators found. Women were twice as likely as men to suffer depression, and the major contributing factor was loss of a partner because of death, divorce or separation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Hannah Rankin, FNP 10850 W Florence Dr Unit 104, Boise, ID 83713-8054 Ph: (740) 646-6809 | Mary Hannah Rankin, FNP 1672 S Woodsage Ave Ste 120, Meridian, ID 83642-8332 Ph: (208) 515-2273 |
News Archive
Probiodrug AG, a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and multiple ascending dose (MAD) study of PQ912 in healthy volunteers.
A new study reports that chronic exposure to arsenic interferes with insulin secretion in the pancreas, which may increase the risk of diabetes.
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The average age at onset of depression was nearly two years younger in low-income countries, the investigators found. Women were twice as likely as men to suffer depression, and the major contributing factor was loss of a partner because of death, divorce or separation.
› Verified 2 days ago